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ABSTRACT The unstable proteins Cdc6p and cdc181 are
essential and rate limiting for the initiation of DNA replication
in Saccharomyces cerevisiae and Schizosaccharomyces pombe,
respectively, and also participate in checkpoint controls that
ensure DNA replication is completed before mitosis is initi-
ated. We have identified Xenopus and human proteins closely
related to Cdc6pycdc18. The human protein, p62cdc6, is en-
coded on chromosome 17q21.3 and includes putative cyclin-
dependent kinase phosphorylation sites, destruction boxes, a
nucleotide bindingyATPase domain, and a potential leucine
zipper. Expression of p62cdc6 mRNA and protein is suppressed
in human diploid fibroblasts made quiescent by serum star-
vation, and peaks as cells reenter the cell cycle and replicate
DNA following serum stimulation. Conservation of structure
among proteins involved in initiation suggests that fundamen-
tal features of replication complexes are maintained in all
eukaryotes.
DNA replication in yeasts is initiated from discrete chromo-
somal locations (replicators) based on the sequential assembly
of a prereplication complex that includes the origin binding
protein ORC (origin recognition complex) (1–10) and several
associated factors. ORC consists of six essential protein sub-
units (4) that have homologues in other yeasts, plants, and
metazoan species (11–16). Binding of ORC to replicator DNA
sequences in vivo can be detected by footprinting techniques at
all stages of the cell cycle, but different patterns of nucleotide
contacts are evident prior to and followingDNA replication (2,
3, 17–19), consistent with the viewpoint that additional factors
interact with ORC to establish a competent complex for
initiation (10).
In budding yeasts this function resides, at least in part, with
the protein encoded by the CDC6 gene (Cdc6p) (5, 19–25).
Fission yeasts contain a closely related protein, cdc181, with
similar properties (26–30). Yeast strains lacking CDC6 are
nonviable, and temperature sensitive cdc6 mutants suffer
growth arrest with partially unreplicatedDNA at the restrictive
temperature (5, 20–22). Even at temperatures permissive for
viability, the frequency at which DNA replication is initiated
from specific replicators is reduced in a strain with a cdc6
mutation (5, 25). Overexpression of cdc181 results in repeated
rounds of DNA replication, in the absence of mitosis, such that
cells accummulate DNA at levels greater than that of normal
diploid cells (28, 29, 31). In contrast, reduced activity of
Cdc6pycdc181 causes underreplication of the genome and
premature entry into mitosis (reductional anaphase) (5, 25–27,
30).
These data establish an important role for Cdc6pycdc181
in the initiation of DNA replication and in mechanisms by
which cells delay mitosis until DNA replication is complete.
We have determined that cells from vertebrate organisms
contain a closely related protein, which we termed p62cdc6.
Several protein structural motifs within human p62cdc6 pre-
dicted from the cDNA sequence have potential importance
in the control of protein stability and function at replication
origins. The chromosomal location and transcriptional start
site of a gene encoding human p62cdc6 were mapped, and
expression of the protein was characterized in relation to
cell cycle progression and mitogenic stimulation in human
cells.
MATERIALS AND METHODS
Cloning. Degenerate oligonucleotide primers for the poly-
merase chain reaction (PCR) were designed using blocks of six
or seven amino acids that were identical, or nearly so, in Cdc6p
and cdc181, but differed in two or more codons from se-
quences conserved among Orc1 proteins (4, 13). An abundant
PCR product closely related to Cdc6p was amplified using
cDNA prepared from Xenopus oocytes as template. 59 and 39
RACE (rapid amplification of cDNA ends) techniques were
used to clone a Xenopus p62cdc6 partial cDNA. Based on the
sequence of the Xenopus p62cdc6, new sets of nondegenerate
oligonucleotide primers were synthesized, and further rounds
of PCR were performed using human cDNA templates. A
687-nt fragment of human p62cdc6 cDNA was radiolabeled and
used as the probe for screening a human cDNA library carried
in lgt10. From 900,000 phage plaques, 5 positive clones were
isolated following three rounds of plaque purification, and
sequencing of inserts defined the complete nucleotide se-
quence of human p62cdc6 cDNA.
Generation of Antibodies and Analysis of mRNA and Pro-
tein Expression. Segments of p62cdc6 cDNA were engineered
into plasmid vectors for expression of recombinant protein in
bacteria (32). Portions of human or Xenopus p62cdc6 were
expressed as glutathione S-transferase fusion proteins in Esch-
erichia coli and purified recombinant proteins were used to
immunize rabbits to generate specific antibodies directed
against p62cdc6. For detection of the human protein, the best
results were obtained with an immunogen consisting of glu-
tathione S-transferase fused to amino acids 51–172 of human
p62cdc6. A purified IgG fraction prepared from serum of a
rabbit inoculated with this antigen was used in the experiments
reported here.
The specificity of this rabbit polyclonal antibody was verified
in three ways: (i) in vitro translated p62cdc6 protein was
specifically immunoprecipitated; (ii) in immunoblots probed at
dilutions of 1y1000 or greater, this antibody recognizes the
truncated recombinant protein used as the immunogen (amino
acids 51–172), full-length recombinant human p62cdc6 in native
form after cleavage from glutathione S-transferase, and an
endogenous human nuclear protein of the predicted molecular
size; (iii) recombinant p62cdc6 bearing a tag and expressed inThe publication costs of this article were defrayed in part by page charge
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HeLa cells was recognized both by anti-p62cdc6 and by anti-
hemagglutination antigen antibodies.
Subconfluent cultures of human diploid Wi38 cells were
serum starved for 48 hr (time 0) and protein or RNA extracts
were prepared from sister cultures at selected times following
addition of complete media (DMEM1 10% FBS). HeLa cells
were cultured in suspension and cells proliferating in logarith-
mic phase were separated using centrifugal elutriation (33).
DNA content of cells stained with propidium iodide was
determined by flow cytometry to calculate the percentages of
cells in G1, S, and G2yM phase at each sampling interval.
Nuclear and cytoplasmic fractions were prepared as described
(34), and proteins were separated by SDSyPAGE before
transfer to nitrocellulose membranes, incubation with primary
and secondary antibodies as described, and visualization of
immune complexes using enhanced chemiluminescence (35).
Total RNA was purified from HeLa or Wi38 cells as described
(35), separated by agarose gel electrophoresis under denatur-
ing conditions, transferred to nitrocellulose membranes, and
probed under conditions of high stringency with human p62cdc6
cDNA radiolabeled with 32P.
Chromosomal Mapping and Determination of the Tran-
scriptional Start Site.Deoxyoligonucleotide primers based on
sequences within human p62cdc6 cDNA were annealed to total
human genomic DNA, or DNA extracted from chromosome-
specific human-rodent hybrid cell lines (36), and products
amplified by PCR. Fluorescence in situ hybridization was
performed as described (37). Genomic DNA clones encoding
human p62cdc6 were cloned from an arrayed cosmid library
limited to segments of human chromosome 17, and restriction
fragments were subcloned in plasmid vectors for PCR, South-
ern blot analysis, and sequencing. The position of the tran-
scriptional start site was mapped by primer extension analysis
using a synthetic deoxyoligonucleotide primer complementary
to a segment from the 59 untranslated region (UTR) of the
cloned human p62cdc6 cDNA, and RNA isolated from asyn-
chronously growing HeLa cells as the template.
RESULTS
cDNA Sequences Encoding Xenopus and Human p62.Using
PCR-based methods, we cloned a partial cDNA encoding a
Xenopus protein closely related to Cdc6p. An identical Xe-
nopus protein has been identified independently by Coleman
et al. (9). Knowledge of the Xenopus p62cdc6 sequence was used
to design new sets of deoxyoligonucleotide primers, which were
successful for generation of specific PCR amplification prod-
ucts encoding segments of human p62cdc6. The largest (687 nt)
fragment of human p62cdc6 cDNA obtained by PCR amplifi-
cation was radiolabeled and used as the probe for screening a
human cDNA library carried in bacteriophage lgt10. In the
first round of screening of 900,000 phage plaques, 18 clones
were positive in duplicate lifts. Of these 18 clones, 5 were
positive in duplicate in a second round of screening. Each of
these 5 clones was isolated following a third round of plaque
purification after plating at low density. Phage DNA was
purified and characterized by PCR and restriction digests.
cDNA inserts were isolated and cloned into a plasmid vector
for sequencing.
The nucleotide sequence of human p62cdc6 cDNA was
determined, and the amino acid sequence predicted from the
largest open reading frame of 1580 nt is shown in Fig. 1a. The
cloned cDNA includes a 59UTR of 210 nt and a 39UTR of 763
nt. A stop codon in the same reading frame is present in the
59 UTR, and multiple in-frame stop codons are present within
the 39 UTR downstream of the stop sequence that terminates
the open reading frame. No poly(A) tail was detected in cloned
cDNA sequences encoding p62cdc6, suggesting that native
transcripts may include additional 39 UTR sequences.
Sequence Conservation of Cdc6-Related Proteins and Po-
tential Structural Motifs Within Human p62cdc6.Alignment of
the amino acid sequence of Cdc6p, cdc181, Xenopus p62cdc6
(partial), and human p62cdc6 is shown in Fig. 1a, and the
position of conserved sequence blocks and potential structural
motifs within the human protein is illustrated schematically in
Fig. 1b. The degree of sequence identity between human,
Xenopus, and yeast cdc6-related proteins is highest in the
midportion of the protein that contains six segments also
conserved amongOrc1-related proteins (4, 13) (Fig. 1 a and b).
Other conserved sequence blocks of near identity among
fungal and vertebrate cdc6-related proteins, but not found in
Orc1 proteins, are also present, and conserved residues are
found throughout the entire protein. Human p62cdc6 appears
to be more closely related to cdc181 and to Orc1p than to
Cdc6p (Fig. 1c). Human p62cdc6 also includes consensus sites
for phosphorylation by cyclin-dependent kinases (38) and
destruction box motifs potentially mediating cell cycle-
dependent degradation of this protein (39). A potential leucine
zipper motif (40) overlaps with conserved sequence block IV.
Chromosomal Location of a Human Gene Encoding p62cdc6.
Two independent sets of primer pairs yielded abundant and
specific amplification products in PCR reactions using total
human genomic DNA as template. Both of these primer pairs
produced identical PCR amplification products using DNA
derived from human–hamster cell hybrids as the template, but
only from those cells bearing human chromosome 17 (data not
shown). No specific PCR amplification products were ob-
served using these primers and hamster or murine genomic
DNA as template, or DNA from hamster–human hybrid lines
bearing any other human chromosome. The position of the
gene encoding p62cdc6 on human chromosome 17 was defined
at higher resolution by fluorescence in situ hybridization, which
localized the gene to 17q21.3, near to the position of the
BRCA1 gene (data not shown). Six overlapping cosmid clones
encoding p62cdc6 were isolated from a chromosome 17-specific
library. Partial sequencing and Southern blot analysis of these
cosmid clones confirmed the presence of sequences identical
to the cloned p62cdc6 cDNA.
Transcriptional Start Site and Proximal Promoter of the
Human p62cdc6 Gene. The 59 end of native p62cdc6 gene
transcripts was mapped by primer extension using RNA pre-
pared from asynchronously growing HeLa cells as the tem-
plate. The major extension product identified the transcrip-
tional start site of the human gene at a position corresponding
to the 59 terminus of the cloned human p62cdc6 cDNA (Fig. 2a).
Sequencing of the immediate 59 f lanking region revealed
putative sites for transcriptional control, including an initiator
element and potential binding sites for E2F proteins (Fig. 2b).
No consensus TATA box is evident. This organization resem-
bles that of other genes (cyclin E and ribonucleotide reduc-
tase) encoding proteins associated with the G1yS transition
(41, 42). A splice junction is present at the point where the
genomic sequence diverges from that of the cloned cDNA (Fig.
2b), defining exon 1 of this gene.
Expression of Human p62cdc6 mRNA and Protein. The
p62cdc6 protein is localized to nuclei of human cells (Fig. 3a).
Cytoplasmic protein extracts contain a cross-reacting antigen
of approximately 35 kDa, the identity of which is unknown at
this time. In HeLa cells separated by centrifugal elutriation,
comparable levels of p62cdc6 were detected in all fractions,
irrespective of the proportion of cells in specific stages of the
cell cycle (Fig. 3b). The abundance of the 35-kDa cytoplasmic
protein also was invariant among the cell populations sepa-
rated by elutriation, and p62cdc6 was not detected in cytoplas-
mic extracts from any cell fraction.
In contrast, expression of p62cdc6 was strictly linked to cell
proliferation in human diploid fibroblasts: the protein is not
detected in quiescent Wi38 cells, but is up-regulated by serum
stimulation coincident with resumption of DNA synthesis (Fig.
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FIG. 1. (a) Multiple alignment of amino acid sequences of human p62cdc6 and related proteins from Xenopus laevis (partial sequence),
Saccharomyces cerevisiae, and Schizosaccharomyces pombe. Amino acid residues that are identical are indicated by dark shading, and conservative
substitutions are indicated by light shading. The six conserved sequence blocks (I–VI) previously found to be shared among the Orc1 family and
fungal Cdc6pycdc181 proteins (4, 13), which include the nucleotide bindingyATPase domain (I and III), are found in the midportion of these
proteins. Outside of this central domain, no regions of sequence similarity with Orc1-related proteins are evident. (b) Potential structural motifs
and highly conserved regions of human p62cdc6. The regions similar to the Orc1 family of proteins are indicated (I–VI). Four other regions of near
identity among the vertebrate and yeast Cdc6-related proteins (black rectangles) are present in the amino or carboxyl-terminal regions, and are
not found in Orc1 proteins from any species. The positions of several additional motifs of potential biological significance also are indicated. (c)
Dendrogram (Genetics Computer Group PILEUP program) indicating the relative similarities between Orc1- and Cdc6-related proteins from fungal
and vertebrate species.
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3c). The induction of p62cdc6 protein by serum in Wi38 cells is
accompanied by an increase in p62 cdc6 mRNA in these cells
(Fig. 3d). Two sizes of human mRNA transcripts hybridize
under conditions of high stringency to the cloned human
p62cdc6 cDNA. A smaller transcript corresponds in size to the
cloned cDNA, whereas a larger 3.2-kb transcript also is
expressed in both HeLa and Wi38 cells. The relative abun-
dance of the two transcripts is comparable in both cell types
and remains constant during induction by serum in Wi38 cells.
As cells recovering from serum starvation enter and complete
mitosis, levels of p62cdc6 protein fall more rapidly than the
decline in p62cdc6 mRNA (Fig. 3 c and d). This observation is
consistent with more rapid degradation of p62 cdc6 during
G2yM phases of the cell cycle. Growth of these human diploid
fibroblasts becomes asynchronous following the first cell cycle
after serum stimulation, such that variations in p62 cdc6 in
subsequent cycles could not be assessed.
DISCUSSION
An extensive body of evidence now supports the replicon
model for initiation of DNA replication in yeasts. Many of the
proteins that interact physically at yeast replication origins
have been identified, and features of the biochemical mecha-
nisms that govern assembly of prereplication complexes and
firing of origins are emerging from studies of these organisms.
Our understanding of replication origins in metazoan species,
including humans, is much less well developed. Progress in this
field has been hampered by an inability to define discrete
replicator regions at high resolution within the human genome,
and by limited information regarding human initiator proteins.
Our current work demonstrates that vertebrates express a
protein closely related to Cdc6p and cdc181 from S. cerevisiae
and Sch. pombe, respectively. These proteins are essential for
DNA replication in yeasts, and are rate-limiting for firing of
individual replication origins. The amino acid sequence of
human p62cdc6 is remarkably conserved by comparison to its
Xenopus and yeast counterparts. Recently, a Cdc6-related
protein identified in Xenopus oocytes (identical to the protein
we found) was shown to be required for initiation of DNA
replication (9). The degree of sequence conservation across
species among Cdc6-related proteins is similar to or greater
than that observed previously for ORC protein subunits (13).
Conservation of structure among proteins involved in the
initiation of replication suggests that fundamental features of
origin function are maintained in all eukaryotes.
The CDC6 and cdc181 genes are expressed in yeast at
specific stages of the cell cycle (25, 27, 30, 43). Expression of
mRNA encoding Cdc6p peaks at the end of M phase in
rapidly cycling S. cerevisiae cells, but a second peak of
expression is evident if G1 is prolonged (25, 43). In contrast,
the cdc181 gene is expressed just prior to the G1 to S phase
transition (27, 30). Both of these proteins are very unstable:
the half-life of cdc181 and Cdc6p has been estimated as 5 min
or less (25, 29). The abundance of cdc181 is down-regulated
by the activity of mitotic cyclins and cyclin-dependent kinase
activity, and up-regulated by cyclin-dependent kinase inhib-
itors (29). The decline in the concentration of Cdc6pycdc181
after the initiation of DNA replication appears to be nec-
essary to release checkpoint controls and permit entry into
mitosis (22). This observation, coupled with a requirement
for renewed synthesis of Cdc6pycdc181 after each round of
DNA replication, has suggested that Cdc6pycdc181 is an
important component of the mechanism to ensure that each
segment of chromosomal DNA is replicated once, and only
once, in each cell cycle.
Our studies of the expression of human p62cdc6 are less
complete, but demonstrate a strict association with cell pro-
liferation and DNA synthesis in the transition of diploid
fibroblasts from a quiescent, nonreplicating state to active cell
cycling. The time course of the induction and subsequent
decline in concentrations of p62cdc6 mRNA and protein are
consistent with changes in both transcription and protein
stability as these cells traverse the cell cycle. By contrast, we
were unable to discern major variations in the abundance of
p62cdc6 in fractions of asynchronously growing HeLa cells
enriched for cells at specific cell cycle stages. The purity of
fractions isolated by centrifugal elutriation may be inadequate,
FIG. 2. (a) Primer extension analysis of HeLa cell RNA showing
the transcriptional start site in relation to the sequence of the p62cdc6
gene cloned from human chromosome 17. The positions of putative
transcriptional control elements (initiator element and potential E2F
binding sites) are indicated. (b) Nucleotide sequence of proximal
promoter region and exon 1 of human gene encoding p62cdc6. Putative
transcriptional control elements are indicated in boldface type, and
restriction sites are underlined. The first nucleotide (11) in the cloned
p62cdc6 cDNA is shown, and a putative splice junction is present at the
point where the genomic sequence diverges from that of the cloned
cDNA, defining exon 1.
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however, to exclude the possibility that nuclear concentrations
of p62cdc6 may fluctuate within narrow segments of the cell
cycle in HeLa cells. In addition, regulation of p62cdc6 expres-
sion across the cell cycle may differ in normal somatic cells by
comparison to immortalized cell lines. It would not be sur-
prising if mechanisms controlling the abundance and activity
of initiatior proteins differ among species or cell types.
The amino acid sequence of human p62cdc6 includes a
number of structural motifs predicted to have bearing on the
regulation and function of the protein in DNA replication. We
present no evidence at this time to demonstrate functions of
these regions, but their presence within the human protein
serves to generate several testable hypotheses. Phosphoryla-
tion by cyclin-dependent kinases may modify protein stability
or influence interactions with other initiator factors. Destruc-
tion box motifs also may influence stability of human p62cdc6,
perhaps by facilitating interactions with components of the
ubiquitin–proteasome pathway of protein degradation (44). A
potential leucine zipper motif provides a site that may be
involved in protein–protein contracts important for origin
function. Within the central region of the protein that is
conserved among Cdc6- and Orc1-related proteins, conserva-
tion of a nucleotide binding domain predicts that human
p62cdc6 has ATPase activity important for its function as a
replication initiation protein. Amino acid substitutions within
the nucleotide bindingyATPase domain of Cdc6p in S. cerevi-
siae impair DNA replication (M. Weinreich and B.S., unpub-
lished data).
We identified and cloned a gene encoding p62cdc6 on human
chromosome 17q21.3. Both HeLa cells and Wi38 human
diploid fibroblasts express two mRNA transcripts of different
sizes that hybridize to the cloned p62cdc6 cDNA under condi-
tions of high stringency. This finding raises the possibility that
a second gene encoding a closely related isoform of p62cdc6 is
present in the human genome, but our data suggest that the
two forms of p62cdc6 mRNA are more likely to arise by
alternative splicing within the 39 UTR of primary transcripts
from a single gene. A putative promoter region from the
human p62cdc6 gene includes potential binding sites for E2F
transcription factors, suggesting parallels to the control of
yeast initiator proteins by SwiyMBF proteins (25).
Cloning of human p62cdc6 provides new opportunities to
increase our understanding of replicator elements within the
human genome and of the molecular events that control the
initiation of DNA replication in human cells. The overrepli-
cation phenotype produced in yeast by forced expression of
cdc181 suggests a potential role for p62cdc6 in human malig-
nancies, either in initial stages of oncogenesis, or in later stages
FIG. 3. (a) Nuclear localization of p62cdc6 in HeLa cells. Specific antisera raised against a recombinant, truncated form of p62cdc6 (R) expressed
in bacteria identified a nuclear protein of 62 kDa in nuclear extracts (N, 20 mg) but not cytoplasmic extracts (C, 50 mg) of asynchronously growing
human HeLa cells. (b) Expression of p62cdc6 in asynchronous HeLa cells (A) and in fractions of HeLa cells separated by centrifugal elutriation.
Flow cytometry results are indicated. (c) Expression of p62cdc6 in quiescent and proliferating human diploid fibroblasts (Wi38 cells). Cells were
grown at low density in the absence of serum for 48 hr and harvested at the indicated times following the addition of serum. The timing of entry
into S phase varied among individual experiments, but flow cytometry indicated that the majority of cells (58–70%) consistently were in S phase
between 18 and 24 hr after the addition of serum, and this percentage declined to less than 27% as growth became asynchronous. In b and c, each
lane was loaded with 32 mg of nuclear protein, and equivalent protein loading was confirmed by staining total proteins with Commassie brilliant
blue. Elutriation and serum stimulation experiments were repeated three or more times with similar results, except that expression of p62cdc6 in
Wi38 cells at the 6-hr time point following serum stimulation was variable and not detectable in some experiments. (d) Northern blot indicating
the abundance of p62cdc6 mRNA transcripts in asynchronous HeLa cells (A) and in Wi38 cells subjected to serum starvation and refeeding, as in
c. Lanes were loaded with 15 mg total RNA and equivalent loading was confirmed by staining of ribosomal RNA subunits with ethidium bromide.
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of tumor progression characterized by chromosomal instability
and polyploidy. It should now be possible to determine
whether inherited or somatic mutations at the p62cdc6 locus are
present in human cancers. In addition, human p62cdc6 repre-
sents a novel target for development of drugs to limit cell
proliferation in human diseases.
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